Literature DB >> 27548902

Association Between Aqueous Flare and Epiretinal Membrane in Retinitis Pigmentosa.

Kohta Fujiwara1, Yasuhiro Ikeda2, Yusuke Murakami2, Shunji Nakatake2, Takashi Tachibana2, Noriko Yoshida2, Shintaro Nakao2, Toshio Hisatomi2, Shigeo Yoshida2, Takeshi Yoshitomi3, Koh-Hei Sonoda2, Tatsuro Ishibashi2.   

Abstract

PURPOSE: Epiretinal membrane (ERM) is a frequent macular complication in patients with retinitis pigmentosa (RP). The etiology of ERM formation in RP is largely unknown. The purpose of this study was to investigate the association between aqueous flare, a surrogate index of intraocular inflammation, and ERM secondary to RP.
METHODS: We retrospectively studied a total of 206 eyes of 117 patients who were diagnosed with typical RP. Aqueous flare values were measured consecutively in 2012 and 2013 using a laser flare cell meter. Spectral-domain optical coherence tomography images and fundus photographs taken on the same day of the aqueous flare measurements were analyzed for ERM detection.
RESULTS: The mean values of aqueous flare, age, and frequency of male sex were significantly higher in the RP patients with ERM compared with the RP patients without ERM (P < 0.0001, P = 0.007, and P = 0.004, respectively). After adjustment for age and sex, the eyes in the highest quartile of aqueous flare had significantly higher odds of having ERM than those in the lowest quartile (odds ratio [OR], 2.68; 95% confidence interval [CI], 1.04-6.93), and the linear trend across flare levels was significant (P = 0.005). In addition, each 1-log-transformed increase in flare values was associated with an elevation of the likelihood of having ERM (OR, 2.59; 95% CI, 1.33-5.06).
CONCLUSIONS: Our analysis demonstrated that elevated aqueous flare is associated with ERM secondary to RP, suggesting that inflammation may be implicated in the pathogenesis of ERM formation in RP.

Entities:  

Mesh:

Year:  2016        PMID: 27548902     DOI: 10.1167/iovs.16-19686

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Association of retinal biomarkers and choroidal vascularity index on optical coherence tomography using binarization method in retinitis pigmentosa.

Authors:  Ebru N Cetin; Osman Parca; Hasan Samed Akkaya; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-12       Impact factor: 3.117

2.  Morphologic characteristics and clinical significance of the macular-sparing area in patients with retinitis pigmentosa as revealed by multicolor imaging.

Authors:  Guodong Liu; Qing Du; Khusbu Keyal; Fang Wang
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

3.  Assessment of Central Visual Function in Patients with Retinitis Pigmentosa.

Authors:  Kohta Fujiwara; Yasuhiro Ikeda; Yusuke Murakami; Takashi Tachibana; Jun Funatsu; Yoshito Koyanagi; Shunji Nakatake; Noriko Yoshida; Shintaro Nakao; Toshio Hisatomi; Shigeo Yoshida; Takeshi Yoshitomi; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

4.  Ocular Spot Fluorometer Equipped With a Lock-In Amplifier for Measurement of Aqueous Flare.

Authors:  Rachapalle Reddi Sudhir; P Pavani Murthy; Sirisha Tadepalli; Subashree Murugan; Prema Padmanabhan; Ashwini Krishnamurthy; Stephanie L Dickinson; R Karthikeyan; Uday B Kompella; Sangly P Srinivas
Journal:  Transl Vis Sci Technol       Date:  2018-12-21       Impact factor: 3.283

5.  Ocular abnormalities in a large patient cohort with retinitis pigmentosa in Western China.

Authors:  Lian Tan; Yanling Long; Ziyang Li; Xi Ying; Jiayun Ren; Cheng Sun; Xiaohong Meng; Shiying Li
Journal:  BMC Ophthalmol       Date:  2021-01-18       Impact factor: 2.209

6.  Aqueous Flare and Progression of Visual Field Loss in Patients With Retinitis Pigmentosa.

Authors:  Kohta Fujiwara; Yasuhiro Ikeda; Yusuke Murakami; Takashi Tachibana; Jun Funatsu; Yoshito Koyanagi; Shunji Nakatake; Shotaro Shimokawa; Noriko Yoshida; Shintaro Nakao; Toshio Hisatomi; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.